Sijbesma, Eline http://orcid.org/0000-0002-4837-7574
Visser, Emira
Plitzko, Kathrin
Thiel, Philipp
Milroy, Lech-Gustav
Kaiser, Markus http://orcid.org/0000-0002-6540-8520
Brunsveld, Luc http://orcid.org/0000-0001-5675-511X
Ottmann, Christian
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (CRC1093)
Article History
Received: 1 April 2020
Accepted: 10 July 2020
First Online: 7 August 2020
Competing interests
: L.B. and C.O. are founders and shareholders of AmbAgon Therapeutics. The remaining authors declare no competing interests.